title: [Results of complex lipid-lowering therapy in patients with a history of acute coronary syndrome].
abstract: Authors aimed to assess how target values in serum lipid concentrations (LDL- and HDL-cholesterol, triglyceride) can be achieved in patients with a history of acute coronary syndrome during follow up in an outpatient cardiology clinic.
  
  
  METHODS
  201 patients with a history of acute coronary syndrome were included and were followed up between January 1 and May 31, 2007.Authors analyzed serum lipid parameters of the patients and the lipid-lowering medications at the time of the first meeting and during follow up lasting two years.
  
  
  RESULTS
  During the enrollment visit only 26.4% of the patients had serum LDL cholesterol at target level, whereas high triglycerides and low HDL cholesterol levels were observed in 40.3% and 33.3% of the patients, respectively. Only 22 patients (10.9%) achieved the target levels in all three lipid parameters. Of the 201 patients, 179 patients participated in the follow up, and data obtained from these patients were analyzed. There was a positive trend toward better lipid parameters; 42.5% of the patients reached the desired LDL-cholesterol target value and 17.3% of the patients had HDL-cholesterol and triglycerides target values.
  
  
  CONCLUSIONS
  These findings are consistent with those published in the literature. Beside the currently used therapeutic options for achieving optimal LDL-cholesterol, efforts should be made to reduce the so-called "residual cardiovascular risk" with the use of a widespread application of combination therapy.
authors.affiliation: Békés Megyei Képviselő-testület Pándy Kálmán Kórháza II. Belgyógyászat-Kardiológia Gyula Semmelweis u. 1. 5701. dani@pandy.hu
authors.forename: Gyoz
authors.initials: G
authors.lastname: Danio
authors.forename: László
authors.initials: L
authors.lastname: Márk
authors.forename: András
authors.initials: A
authors.lastname: Katona
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000517:prevention & control*; D000368:Aged; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention / Q000379:methods*; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides